Patents by Inventor Norma V. Nenonene

Norma V. Nenonene has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pre-Mixed, Ready-To-Use Pharmaceutical Compositions
    Publication number: 20230165962
    Abstract: Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular conditions.
    Type: Application
    Filed: December 9, 2022
    Publication date: June 1, 2023
    Inventors: Michelle Renee Duncan, Supriya Gupta, David Hartley Haas, Norma V. Nenonene, Camellia Zamiri
  • Pre-mixed, ready-to-use pharmaceutical compositions
    Patent number: 11547758
    Abstract: Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular conditions.
    Type: Grant
    Filed: July 24, 2020
    Date of Patent: January 10, 2023
    Assignee: EKR Therapeutics, LLC
    Inventors: Michelle Renee Duncan, Supriya Gupta, David Hartley Haas, Norma V. Nenonene, Camellia Zamiri
  • Pre-Mixed, Ready-To-Use Pharmaceutical Compositions
    Publication number: 20210038717
    Abstract: Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular conditions.
    Type: Application
    Filed: July 24, 2020
    Publication date: February 11, 2021
    Inventors: Michelle Renee Duncan, Supriya Gupta, David Hartley Haas, Norma V. Nenonene, Camellia Zamiri
  • Pre-mixed, ready-to-use pharmaceutical compositions
    Patent number: 10758616
    Abstract: Provided herein are ready-to-use premixed pharmaceutical compositions of nicardipine or a pharmaceutically acceptable salt and methods for use in treating cardiovascular and cerebrovascular conditions.
    Type: Grant
    Filed: June 18, 2018
    Date of Patent: September 1, 2020
    Assignee: EKR Therapeutics, Inc.
    Inventors: Michelle Renee Duncan, Supriya Gupta, David Hartley Haas, Norma V. Nenonene, Camellia Zamiri